York / Paris / Turin / Milan / Bethesda / Lyon / East Melbourne / Salut Púbñica / Baltimore / Atlanta / Beijing / Cape Town / Tampa / Lisbon / Brussels / /
Company
INTRODUCTION A / EGL / /
Continent
America / Europe / Americas / Africa / Asia / South America / /
Country
Rwanda / Netherlands / South Africa / Peru / France / Japan / Suriname / Panama / Guyana / Canada / Australia / Portugal / United Kingdom / China / Israel / Finland / Italy / Mexico / Sweden / Belgium / United States / Argentina / Spain / / /
Event
FDA Phase / /
Facility
Moffitt Cancer Centre / University of Cape Town / Kimmel Cancer Center / Groote Schuur Hospital / Cancer Institute / European Institute of Oncology / University of California / Bichat University Hospital / Scientific Institute of Public Health Brussels / National Cancer Institute / Western Galilee Hospital / / /
IndustryTerm
treatment of cancers / PREVENTION OF CERVICAL CANCER / treatment of HPV-related disease / treatment for CIN to prevent cervical cancer / Cancer Prevention / Prevention of AIN and anal cancer / multidisciplinary / prevention of anogenital disease / /
MedicalCondition
sexually transmitted disease / oral cavity carcinomas / anogenital HPV infection / invasive penile tumours / HIV / anal HPV infection / anogenital disease / verrucous tumours / HPV infection / precancerous conditions / malignant disorders / neck cancer / squamous cell carcinomas / squamous cell cancer / HPV Associated Diseases / HPV16 infection / RELATED TO HPV INFECTION hrHPV infection / oral HPV infection / Cancer / invasive penile cancers / benign diseases / oral cancers / HPV / cervical cancer / penile cancer / Oropharyngeal cancer HPV / itching / Cervical cancer HPV / cancers HPV / invasive cervical and other HPV-related disease / diseases / high-risk HPV infection / infection / Vulvar Disease / tumours / cancer of the pharynx / oral cancer / anal and oropharyngeal carcinoma / anal cancer / warts / warty tumours / recurrent respiratory papillomatosis / infectious / J Cancer / HPV-positive vulvar cancers / tonsillar cancer / genital warts / CIN / invasive vulvar cancers / low-risk HPV Genital warts / cancers / common cancer / disease / anal and penile cancer / vulvar cancer / vulva cancers / HPV-related oropharyngeal cancer / oral cavity cancers / anal cancers / annual cervical cancer / oro-pharynx cancers / vulvar cancers / oropharynx cancers / oropharyngeal squamous cell carcinoma / oral cavity cancer / Cancer of the vulva / /
Western Galilee Hospital / Belgium Unit of Infections and Cancer / World Health Organization / European Institute of Oncology / Gynecology Division / University of Cape Town / Scientific Institute of Public Health Brussels / Preventive Gynecology Unit / Department of Medicine / Division of Viral Oncology / Institut Català d'Oncologia / Bar-Ilan University Faculty of Medicine / Department of Obstetrics and Gynecology / National Cancer Institute / Kimmel Cancer Center / National Institute of Health / Moffitt Cancer Centre / Unit of Cancer Epidemiology / Division of Cancer Epidemiology and Genetics / Department of Cancer Epidemiology / Department of Gastroenterology and Proctology / Department of Obstetrics and Gynaecology / Institute of the Cervix / Centers for Disease Control and Prevention / University of California / San Francisco / San Francisco / Bichat University Hospital / U.S. Food and Drug Administration / Victorian Cytology Service / Hull York Medical School / Groote Schuur Hospital / Division of Cancer Prevention and Control / Chinese Academy of Medical Sciences / International Agency for Research / /
Microsoft Word - Roadmap2012_R1_clean10.doc